Literature DB >> 22693372

BRCA1 and BRCA1 Genes and Inherited Breast and/or Ovarian Cancer: Benefits of Genetic Testing.

Kumaravel Somasundaram1.   

Abstract

The breast cancer associated genes BRCA1 and BRCA2 were discovered in 1994 and 1995 respectively. Since then in addition to our understanding how these proteins function in particular reference to DNA repair, enormous amount of knowledge has been gained regarding genetic epidemiology of inherited breast and ovarian cancer, mutation prevalence among different ethnic groups, presence of founder mutations, varying penetrance, genetic testing and potential management options of mutation carriers. This review will focus on the status of understanding of the role of BRCA1 and BRAC2 mutations among Indian women, structure and biology of these two genes, different methods used for mutation detection and different management options available for BRCA1 and BRCA2 mutation carriers.

Entities:  

Keywords:  BRCA1; BRCA2; Familial breast and/or ovarian cancer; Inherited breast cancer

Year:  2011        PMID: 22693372      PMCID: PMC3244237          DOI: 10.1007/s13193-011-0049-7

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  24 in total

1.  Conformation-sensitive gel electrophoresis for detecting BRCA1 mutations.

Authors:  Smita Lakhotia; Kumaravel Somasundaram
Journal:  Methods Mol Biol       Date:  2003

2.  BRCA1 variants in a family study of African-American and Latina women.

Authors:  Roberta McKean-Cowdin; Heather Spencer Feigelson; Lucy Y Xia; Celeste Leigh Pearce; Duncan C Thomas; Daniel O Stram; Brian E Henderson
Journal:  Hum Genet       Date:  2005-02-23       Impact factor: 4.132

3.  Polygenic inherited predisposition to breast cancer.

Authors:  B A J Ponder; A Antoniou; A Dunning; D F Easton; P D P Pharoah
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

Review 4.  Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review.

Authors:  Ansgar Gerhardus; Henriette Schleberger; Brigitte Schlegelberger; Dorothea Gadzicki
Journal:  Eur J Hum Genet       Date:  2007-03-07       Impact factor: 4.246

5.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

Authors:  J Peto; N Collins; R Barfoot; S Seal; W Warren; N Rahman; D F Easton; C Evans; J Deacon; M R Stratton
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

6.  Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.

Authors:  Suresh Hedau; Neeraj Jain; Syed A Husain; Ashish K Mandal; Gibanananda Ray; M Shahid; Ravi Kant; Vishal Gupta; Nootan K Shukla; Suryanarayan S V Deo; Bhudev C Das
Journal:  Breast Cancer Res Treat       Date:  2004-11       Impact factor: 4.872

7.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.

Authors:  Sunita Saxena; Anurupa Chakraborty; Mishi Kaushal; Sanjeev Kotwal; Dinesh Bhatanager; Ravindar S Mohil; Chintamani Chintamani; Anil K Aggarwal; Veena K Sharma; Prakash C Sharma; Gilbert Lenoir; David E Goldgar; Csilla I Szabo
Journal:  BMC Med Genet       Date:  2006-10-04       Impact factor: 2.103

9.  How many more breast cancer predisposition genes are there?

Authors:  D F Easton
Journal:  Breast Cancer Res       Date:  1999-08-23       Impact factor: 6.466

10.  Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.

Authors:  Mani T Valarmathi; Meenakshi Sawhney; Suryanarayana S V Deo; Nootan K Shukla; Satya N Das
Journal:  Hum Mutat       Date:  2004-02       Impact factor: 4.878

View more
  2 in total

1.  Feasibility of genetic testing for cancer risk assessment programme in Nigeria.

Authors:  Prisca O Adejumo; Toyin I G Aniagwu; Olutosin A Awolude; Abiodun O Oni; Olubunmi O Ajayi; Omolara Fagbenle; Dasola Ogungbade; Makayla Kochheiser; Temidayo Ogundiran; Olufunmilayo I Olopade
Journal:  Ecancermedicalscience       Date:  2021-09-07

Review 2.  Breast cancer in the era of integrating "Omics" approaches.

Authors:  Claudia Rossi; Ilaria Cicalini; Maria Concetta Cufaro; Ada Consalvo; Prabin Upadhyaya; Gianluca Sala; Ivana Antonucci; Piero Del Boccio; Liborio Stuppia; Vincenzo De Laurenzi
Journal:  Oncogenesis       Date:  2022-04-14       Impact factor: 6.524

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.